Aurinia Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $59,867 | $67,771 | $57,192 | $50,303 |
Gross Profit | 54,315 | 61,736 | 48,283 | 42,551 |
EBITDA | 7,181 | 20,908 | 4,402 | -3,880 |
EBIT | 2,319 | 16,015 | -441 | -8,727 |
Net Income | 1,429 | 14,350 | 722 | -10,749 |
Net Change In Cash | 59,867 | 67,771 | 57,192 | 50,303 |
Free Cash Flow | 30,058 | 16,900 | 15,779 | -18,609 |
Cash | 83,433 | 37,142 | 33,406 | 64,459 |
Basic Shares | 147,675 | 145,651 | 144,110 | 144,013 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $235,133 | $175,513 | $134,030 | $45,605 |
Gross Profit | 206,885 | 161,365 | 128,366 | 44,514 |
EBITDA | 31,728 | -63,047 | -108,764 | -177,445 |
EBIT | 12,283 | -74,694 | -111,470 | -180,206 |
Net Income | 5,752 | -78,020 | -108,180 | -180,966 |
Net Change In Cash | 235,133 | 175,513 | 134,030 | 45,605 |
Cost of Revenue | -40,450 | |||
Free Cash Flow | 44,107 | -34,179 | -79,821 | -159,193 |
Cash | 83,433 | 48,875 | 94,172 | 231,900 |
Basic Shares | 146,194 | 143,236 | 141,915 | 129,369 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.01 |
2024-09-30 | $0.10 |
2024-06-30 | $0.01 |
2024-03-31 | -$0.03 |
